Cargando…
Non-invasive saliva specimens for the diagnosis of COVID-19: caution in mild outpatient cohorts with low prevalence
Autores principales: | Skolimowska, Keira, Rayment, Michael, Jones, Rachael, Madona, Pinglawathee, Moore, Luke S.P., Randell, Paul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7367808/ https://www.ncbi.nlm.nih.gov/pubmed/32688069 http://dx.doi.org/10.1016/j.cmi.2020.07.015 |
Ejemplares similares
-
Caution required with use of ritonavir-boosted PF-07321332 in COVID-19 management
por: Heskin, Joseph, et al.
Publicado: (2022) -
Real-world evaluation of COVID-19 lateral flow device (LFD) mass-testing in healthcare workers at a London hospital; a prospective cohort analysis
por: Lamb, Georgia, et al.
Publicado: (2021) -
Early identification of high-risk individuals for monoclonal antibody therapy and prophylaxis is feasible by SARS-CoV-2 anti-spike antibody specific lateral flow assay
por: Pallett, Scott J.C., et al.
Publicado: (2022) -
Saliva as a non-invasive specimen for COPD assessment
por: Melo-Dias, Sara, et al.
Publicado: (2022) -
Saliva sample as a non-invasive specimen for the diagnosis of coronavirus disease 2019: a cross-sectional study
por: Pasomsub, E., et al.
Publicado: (2021)